Talk:Methylphenidate

Regarding the edits made by one user behind multiple anonymous IP addresses:

• @2601:1c2:4c00:81a0:ad9e:4b29:b453:7700
• @2601:1c2:4c00:81a0:3453:2c7:e09e:5968
• @2601:1c2:4c00:81a0:307f:85d:6987:b494
• @174.204.192.184

I will catalogue the edits made below: Testem (talk) 19:16, 28 June 2025 (UTC)Reply

The article currently refers to the drug simply as methylphenidate, without noting that the clinically used form is usually the hydrochloride salt (methylphenidate hydrochloride). Should the article clarify this distinction?

Other Wikipedia drug pages sometimes specify the salt (e.g., amphetamine sulfate), especially where the salt form is the one actually marketed and dispensed. Since methylphenidate is almost always prescribed as the hydrochloride salt, it might be helpful for accuracy and reader understanding if the article mentioned this. 92.236.60.66 (talk) 08:59, 25 September 2025 (UTC)Reply

Added the hydrochloride salt is the most common formulation to the Methylphenidate#Available_forms section. — Preceding unsigned comment added by Boghog (talk • contribs) 09:34, 25 September 2025 (UTC)Reply

Several IP user accounts, which I presume to be the same person, persistently add the brand name "Medikinet" without an edit summary. It is not necessary to add any brand name you can think of and add them to the lead; that would lead to clutter. Additionally, an edit summary is never provided. I do not want an edit war, and I believe I have not been proactive enough in preventing one, which I apologize for. Please discuss before making these revisions instead of persistently reverting them without explanation. I will not personally be reverting anymore at this time.

The IP addresses:

@23.146.243.218

@23.146.243.199

@23.146.243.203

@23.146.243.215 Slothwizard (talk) 16:06, 27 September 2025 (UTC)Reply

In a moment, I am going to revise the lead so that it reflects a more accurate summary of the article's contents. Currently, one paragraph of the lead reads as follows:

Methylphenidate is known to have side effects and can cause withdrawal symptoms after regular use.

Virtually every drug has side effects; this tells the general readership nothing about methylphenidate. I don't know why withdrawal symptoms is notable enough to be mentioned as the lone adverse effect of the drug, given that the vast majority of medical users of this drug (i.e., the largest cohort of methylphenidate users in general) don't experience psychological dependence and hence withdrawal.^[1]

When I publish the revised lead, feel free to use this talk page topic to discuss any improvements. Professional Crastination (talk) 04:52, 25 November 2025 (UTC)Reply

The lead actually used to look very similar to the way you've changed it to look with your most recent edit. I'm not sure at what point it got dumbed down to such an absurd extent as it was prior to your (very much welcomed) changes. It looks like it was still in decent shape 6 years ago, so it must have been sometime in the past 6 years.

Unfortunately Wikipedia articles rot over time, no matter how much effort is put into perfecting them, they always start falling apart once enough of the core contributors can't keep enough of their attention on constantly monitoring them for changes, or stop having time/motivation available to dedicate to continued ongoing maintenance (including fighting the flood of often well intentioned but ultimately highly damaging edits by inexperienced users unaccustomed to writing in this topic area).

I'm still quite proud of all the work I did on this article 8–10 years ago, but it is dispiriting to see how many parts have gotten worse over time and the sheer amount of unnecessary churn and rot this page has seen since then. On the other hand, it's very encouraging to see new editors step up and contribute. We've lost a lot of the old guard of medical editors over the past decade, but seeing newer editors like yourself step up and start making valuable high quality balanced contributions from a well informed balanced perspective to these neglected medical articles gives me some hope for the future. Thank you for the changes, they were sorely needed. Garzfoth (talk) 22:58, 26 November 2025 (UTC)Reply

Thank you for the kind words, Garzfoth :). I agree that it's unfortunate that this article is so regularly subject to backward revisions, and in the worst-case outright vandalism. IMO this article has a lot of potential, if only because the availability of published research is analogous to amphetamine which itself is a featured article. In the case of research for its medical uses and safety, an argument can be made that methylphenidate is even more researched than amphetamine, given its implied clinical preference to amphetamine in countries outside of North America and Australia.^[2] I am quite biased in comparing this article to the standard of the amphetamine article though - that's because I spend most of my time on Wikipedia maintaining and adding content on its clinical evidence beyond ADHD.

I would personally love to see this article improved. However, whilst I would have liked to have volunteered to overhaul some of the content right away, I've already decided to begin draftinga major rewrite of the clonidine article after I was assigned to PACU at the hospital I work at. Clonidine's versatile clinical utility is interesting and its used off-label extensively in recovery settings, so I believe the general readership would benefit from having a high-quality Wikipedia article that discusses the current consensus on clonidine's safety and efficacy; (IMO) the current revision does a bad job of that and in general the article is all over the place. Hopefully I'll have the revised clonidine#Medical_uses section done over the next week or two. Once that's done, I may take a look at methylphenidate again and see if I can think of any beneficial changes. Professional Crastination (talk) 07:31, 29 November 2025 (UTC)Reply

Well done and thank you. The current state, as of 30th November 2025 is a significant improvement from the version from 11th November, which was a 30 item list of every possible side effect, repeating the side effects section of the article. I'm not sure if dedicating 1/3rd of the lead to side-effects is ideal, perhaps a sentence about history and one about chemistry might also be worth adding? Testem (talk) 14:54, 4 December 2025 (UTC)Reply

Hi! Never posted on here before but I came across a study that shows methylphenidate has a binding affinity for the sigma 1 receptor with a ki value of 14.91 + 4.22 uM, which may be partially involved in its activity. Methylphenidate Enhances NMDA-Receptor Response in Medial Prefrontal Cortex via Sigma-1 Receptor: A Novel Mechanism for Methylphenidate Action https://pmc.ncbi.nlm.nih.gov/articles/PMC3527396/ AliceinWonderland1225 (talk) 09:50, 17 January 2026 (UTC)Reply

@AliceinWonderland1225:

14.91±4.22 µM = 14,910±4220 nM

A Ki of >10,000 nM is generally considered to have very low affinity, with little to no practical effect. A Ki of nearly 15,000 is exceptionally low affinity.

It is arguable if such poor binding affinity merits inclusion in the receptor affinity tables. Garzfoth (talk) 14:40, 17 January 2026 (UTC)Reply

@Garzfoth Understandable. Guess my thought process had a bit to do with some of the areas in the paper where with dopamine and norepinephrine depleted higher doses of methylphenidate still showed activity via action at NMDA. I'd be curious to see if D-Threo-Methylphenidate has a higher affinity for Sigma 1 similar to how its what mainly has affinities for transporters AliceinWonderland1225 (talk) 16:50, 17 January 2026 (UTC)Reply

It's more than likely only relevant in higher doses anyway though. AliceinWonderland1225 (talk) 16:52, 17 January 2026 (UTC)Reply